This content is machine translated Moderate to severe atopic dermatitis Biologic therapy in the changing times: “Best practice” approaches in focus In addition to the new systemic drugs recently launched, several active substances are currently in development. These include some biologics in advanced stages of clinical testing. Overall, the future prospects…
View Post 4 min This content is machine translated Atopic dermatitis JAK inhibition as a mode of action – an update. Janus kinase (JAK) inhibitors are a promising new treatment option for adult patients with atopic eczema, given their rapid relief of pruritus and inflammatory lesions. In addition to baricitinib, which…
View Post 4 min This content is machine translated Allergic rhinitis Nose runs – research too Allergic rhinitis (AR) is one of the most common diseases in the world with an incidence of 10% to 40% in the population. Upper respiratory tract disease is manifested by…
View Post 12 min This content is machine translated Atopic dermatitis Digital support options for treatment The terms atopic dermatitis, atopic eczema and atopic dermatitis stand for a global skin disease, with children and adolescents being the most frequently affected. In 2020, a systematic review included… CME-Test
View Post 3 min This content is machine translated Phase IIa study Tocilizumab for the treatment of Schnitzler syndrome Schnitzler syndrome is a rare autoinflammatory disorder. Core symptoms include chronic, recurrent hives. In particular, for patients who do not respond to anti-IL1 therapy, there is a need for new…
View Post 5 min This content is machine translated Dust mite allergy Tiny components with a big impact Dust mite allergy is characterized by year-round symptoms of the nose, lungs and/or eyes. Inadequate diagnosis and treatment may favor the development of allergic asthma (“floor change”). If symptomatic therapy…
View Post 4 min This content is machine translated Sublingual immunotherapy New pill against the mite The past year has not brought much news in terms of large studies on sublingual immunotherapy (SLIT) that are suitable for approval. There were new findings, particularly on the effect…
View Post 15 min This content is machine translated Self-management of teens with allergies or asthma Somehow it doesn’t work: adherence and compliance in adolescents Adolescents are difficult, don’t want to go to therapy, are unmotivated, are non-compliant: this is our common image of chronically ill adolescents. Is that really so? Or maybe it’s the… CME-Test
View Post 3 min This content is machine translated Allergic rhinitis: sublingual specific immunotherapy Allergen extracts melt under the tongue Allergen-specific immunotherapy is currently the only causal therapy for the treatment of immediate-type allergies such as allergic rhinitis. In contrast to symptomatic therapies, the goal is to achieve sustained immunological…
View Post 6 min This content is machine translated Dupilumab for the treatment of atopic dermatitis Reduction of Th2-mediated inflammation – therapeutic success also in adolescents Th2-mediated inflammatory processes play a central pathogenetic role in atopic dermatitis. This is the therapeutic target of the IL4/IL13 inhibitor dupilumab, which was recently approved in Switzerland also for adolescents…
View Post 3 min This content is machine translated Baricitinib First oral JAK inhibitor approved for the treatment of atopic dermatitis The use of small molecule drugs for the treatment of atopic dermatitis has been investigated for some time. With the approval of the Janus kinase (JAK) inhibitor baricitinib, a new…
